Iptakalim Hydrochloride

盐酸埃他卡林

Report date: 2023/04/21 13:49:41
NME

Base Information

Drug NameIptakalim Hydrochloride
Drug Alias Name埃他卡林
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel agonists
TargetsPotassium channel
Therapy Area/IndicationsEssential HypertensionPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Saide Weikang Medicine InstituteJiangsu Nhwa Pharmaceutical Co LtdChinese Academy Of Military Medical Sciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInstitute Of Toxicants And Drugs, Academy Of Military Medical Sciences, Chinese People'S Liberation ArmyBeijing Enhua Medicine Research InstituteBeijing Saide Weikang Medicine Institute
Inactive CompaniesJiangsu Nhwa-Sede Pharm Co Ltd
Active IndicationsEssential HypertensionPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A